Terminalia bellirica
What's the taxonomical classification of Terminalia bellirica?
Terminalia bellirica belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is situated in the class Equisetopsida and the subclass Magnoliidae. Following the taxonomic hierarchy through the order Myrtales, the plant is placed within the family Combretaceae. Finally, it is categorized under the genus Terminalia, with its specific designation being the species bellirica.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
| Species | bellirica |
What are the morphological characteristics of this plant?
Terminalia bellirica has small, simple, alternate leaves that are typically elliptic or oblong in shape with obtuse or rounded apices. The leaves possess a leathery texture and a smooth margin, often appearing dark green on the upper surface. This tree features a sturdy trunk with bark that becomes fissured or scaly as the specimen matures. The inflorescences are small and axillary, giving rise to tiny, inconspicuous flowers. These flowers eventually develop into small, fleshy drupes that serve as the plant's fruit.
What is the geographical distribution of this plant?
This plant is native to the tropical and subtropical regions of South and Southeast Asia, specifically spanning from India and Sri Lanka to Thailand, Vietnam, and parts of Indonesia. It thrives primarily in moist, lowland environments such as riverbanks and coastal areas where humidity is high. The species is commonly found in deciduous forests and monsoon forests across its broad range. Its distribution is closely tied to monsoonal climates that provide seasonal rainfall necessary for its growth. Because of its adaptability to warm climates, it can be found in diverse island ecosystems throughout the Indo-Malayan realm.
How is this plant cultivated?
This plant Terminalia bellirica thrives in tropical and subtropical climates when grown in well-drained, loamy soils with moderate to high rainfall.
It is typically propagated through seeds or cuttings and requires full sunlight to support its vigorous growth patterns. As a large deciduous tree, it reaches maturity in forest environments where it can access deep groundwater supplies. Regular monitoring for pests and maintaining consistent moisture during the early seedling stages are essential for successful establishment.
Once established, the tree is highly resilient and serves as a valuable source of medicinal belleric myrobalan.
What parts of this plant are used medicinally?
This plant Terminalia bellirica provides medicinal benefits through the utilization of its bark, fructus, leaf, seed, and stem. The fructus, or fruit, is frequently employed in traditional formulations to support digestive health and respiratory function. Extracts from the bark and stem are often used for their astringent properties to treat various inflammatory conditions. The leaves serve as a natural remedy for skin ailments and topical applications. Additionally, the seeds contain specific compounds that contribute to the overall therapeutic profile of the species.
According to a study published by "Journal of chromatographic science", the bark and fruits of Terminalia bellirica contain five tannin-related marker constituents. These constituents include gallic acid (GA), corilagin (CL), chebulagic acid (CB), ellagic acid (EA), and chebulinic acid (CN). The limit of detection for these analytes was 1.0, 0.5, 1.0, 0.5, and 1.0 μg/mL for GA, CL, CB, EA, and CN, respectively. Additionally, the limit of quantification was recorded as 2.5, 1.0, 2.5, 1.0, and 2.5 μg/mL for GA, CL, CB, EA, and CN. The study observed good linearity with r(2) > 0.992 for all five compounds in the extracts.
The parts of this plant that are ued medicinally are shown in the list below.
- bark
- fructus
- leaf
- seed
- stem
What traditional systems uses this plant?
This plant, Terminalia bellirica, has been utilized for centuries across diverse healing traditions including Ayurveda, Siddha, Unani, Indian medical practices, and Egyptian folk medicine to treat various ailments. In Ayurvedic and Siddha systems, the fruit is a key component of Triphala, used primarily to balance the doshas and support digestive health. Unani practitioners employ its properties to manage inflammatory conditions and respiratory issues through specialized herbal formulations. Indian medical practices have historically relied on its astringent qualities to treat wounds and skin disorders. Additionally, historical records suggest its use in Egyptian folk medicine as a remedy for various gastrointestinal disturbances.
According to a study published by "Biogerontology", Terminalia bellirica is one of 6 herbs comprising an Ayurvedic polyherbal extract. This extract is mentioned in the Charaka Samhita, which is the classical text of Ayurveda, as an effective anti-hyperglycemic agent. When used at a dose of 0.01 µg/ml, the polyherbal extract containing Terminalia bellirica was able to enhance mean lifespan by 16.09% (P < 0.0001) in C. elegans. The study suggests that this polyherbal formulation might play an important role in regulating aging and complications like diabetes.
The hystorical systems that uses this plant are shown in the list below.
- Ayurveda
- Egyptian folk medicine
- Indian medical practices
- Siddha
- Unani
What are the pharmacological activities of Terminalia bellirica?
This plant has significant pharmacological activities including anti-inflammatory, antioxidant, antibacterial, antimicrobial, and antidiabetic properties. These diverse biological actions are primarily attributed to the high concentration of bioactive compounds like tannins and polyphenols found in its fruits. The antioxidant capacity helps neutralize free radicals, which protects cells from oxidative stress and damage. Furthermore, its antimicrobial and antibacterial effects allow it to combat various pathogenic microorganisms effectively. Finally, the plant demonstrates antidiabetic potential by helping to regulate blood glucose levels in metabolic studies.
According to a study published by "Journal of traditional and complementary medicine", Terminalia bellirica was evaluated in water, ethanol, and hexane for COX-1 and 2 inhibitory and antioxidant activities. The extracts of Terminalia bellirica showed significant COX-2 selective inhibition at 73.34 %. The ethanol extract of the plant demonstrated effective DPPH, OH, and superoxide radical scavenging activity. In vivo studies show that Terminalia bellirica had a significant impact on the inhibition of edema formation. Furthermore, the cytotoxicity evaluation of the ethanolic fraction indicates that the sample has no effect on cell viability.
The primary pharmacological activities of this plant are shown in the list below.
- antioxidant
- antibacterial
- anti-inflammatory
- antidiabetic
- antimicrobial
What medicinal compounds this plant contains?
This plant contains a diverse profile of bioactive medicinal compounds including chebulagic acid, chebulic acid, chebulinic acid, corilagin, and gallic acid. These specific polyphenolic constituents are primarily responsible for the plant's significant antioxidant and anti-inflammatory properties. The presence of chebulagic and chebulic acids contributes to its traditional use in digestive and metabolic health treatments. Additionally, corilagin and gallic acid provide further therapeutic potential through their ability to combat oxidative stress in various biological systems. Together, these chemical components form the foundation of the plant's pharmacological efficacy.
According to a study published by "Journal of chromatographic science", five tannin-related marker constituents were identified and quantified in the bark and fruit extracts of Terminalia bellirica. These specific medicinal compounds include gallic acid (GA), corilagin (CL), chebulagic acid (CB), ellagic acid (EA), and chebulinic acid (CN). The limits of detection for these analytes were 1.0, 0.5, 1.0, 0.5, and 1.0 μg/mL for GA, CL, CB, EA, and CN, respectively. Additionally, the limits of quantification were 2.5, 1.0, 2.5, 1.0, and 2.5 μg/mL for GA, CL, CB, EA, and CN. The study observed good linearity with r(2) > 0.992 for all five compounds.
The primary medicinal compounds of this plant are shown in the list below.
- chebulagic acid
- chebulic acid
- chebulinic acid
- corilagin
- gallic acid
What health conditions is this plant used for?
This plant is used for managing diabetes mellitus, diarrhea, gastric ulcer, constipation, and dyspepsia. Its medicinal properties are frequently utilized in traditional practices to regulate blood sugar levels in patients with metabolic issues. For digestive ailments, the plant helps alleviate symptoms of indigestion and dyspepsia. It also serves as a remedy to soothe gastric ulcers and restore balance to the gastrointestinal tract. Additionally, its effects can be applied to treat both diarrhea and constipation to stabilize bowel movements.
According to a study published by "Pharmaceuctical biology", Terminalia bellerica Roxb. is used in Indian traditional systems of medicine to treat diabetes mellitus. Octyl gallate isolated first time from the fruit rind of T. bellerica significantly (p < 0.05) reduced plasma glucose to near normal values of 108.47 ± 6.9 mg/dl after 14 d when administered at a dose of 20 mg/kg. This compound was administered to diabetic Wistar rats at different doses of 5, 10 and 20 mg/kg (body weight) for 28 d. The plant's isolated compound significantly increased plasma insulin, C-peptide, total protein, albumin, tissue glycogen, and body weight. Additionally, it markedly decreased serum total cholesterol, triglyceride, LDL-cholesterol, urea, uric acid and creatinine in diabetic rats.
The main health conditions this plant is used for are shown in the list below.
- diarrhea
- dyspepsia
- gastric ulcer
- constipation
- diabetes mellitus
What are the herbal preparations of this plant?
This plant is used to create diverse medicinal herbal preparations including Majoon-Najah, Nawametho decoction, Triphala, Pilonil Tablet, and a 95% ethanol extract. These various forms allow for different methods of administration and therapeutic applications in traditional and modern medicine. For example, the Triphala formula combines this species with two other fruits to support digestive health. Specialized formulations like the Majoon-Najah paste or the Nawametho decoction provide concentrated doses for specific ailments. Furthermore, the 95% ethanol extract serves as a potent concentrated substance for research and pharmaceutical development.
According to a study published by "Current drug research reviews", Terminalia bellirica is one of the major constituents of the Majoon-Najah formulation. This medicinal preparation was evaluated using 30 adult male albino guinea pigs assigned to 5 groups. The study involved administering the formulation intragastrically for 15 days, followed by Cadmium chloride at a dose of 3 mg/kg/day from days 8 to 15. Terminalia bellirica, as part of the MN and MNHE, helped protect the liver from injury by lowering raised parameters and increasing enzymatic antioxidants. The protective action is exerted by scavenging free radicals, decreasing malondialdehyde levels, and down-regulating pro-inflammatory indicators.
The main herbal preparations of this plant are shown in the list below.
- Majoon-Najah
- Nawametho decoction
- Triphala
- Pilonil Tablet
- 95% ethanol extract
What side effects this plant can have?
This plant can cause serious health issues including liver damage, hepatotoxicity, cytotoxicity, an anticoagulant effect, and diarrhea. High doses or improper usage may lead to significant liver damage through mechanisms associated with hepatotoxicity. Scientific studies have also identified potential cytotoxicity, which refers to the plant's ability to damage or kill living cells. Additionally, the presence of compounds that produce an anticoagulant effect can increase the risk of bleeding in certain individuals. Digestive upset, specifically diarrhea, is another common side effect reported during consumption.
According to a study published by "Iranian biomedical journal", Terminalia bellirica showed a promising anticoagulant effect with a P value of 0.0019. This effect was evaluated using three concentrations of ethanol extracts consisting of 1, 10, and 100 µg per ml. The study utilized in vitro prothrombin time and activated partial thromboplastin time coagulation tests to assess the plant. This anticoagulant activity was identified for the first time in this specific plant. Further in vivo study and mechanism of action assays are required for this candidate.
The main side effects this plant can have are shown in the list below.
- anticoagulant effect
- cytotoxicity
- diarrhea
- hepatotoxicity
- liver damage
What herbs are paired with Terminalia bellirica?
This plant Terminalia bellirica pairs effectively with other Ayurvedic herbs such as Phyllanthus emblica and Operculina aggregata to form the classical Triphala formulation.
These three botanical components work synergistically to support digestive health and systemic detoxification. When used in medicinal preparations, it is often combined with black pepper to enhance the bioavailability of its active compounds. Practitioners may also blend it with ginger or cumin to balance its astringent properties during culinary or therapeutic applications.
These specific combinations are chosen to maximize the antioxidant and anti-inflammatory effects of the fruit.